McCormack D L
Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City.
Ophthalmic Surg. 1990 Jul;21(7):508-12.
Pupils are often dilated for examination the day before surgery and again on the day of surgery. The following experiment was performed to determine the effect of serial doses of two commonly used mydriatic agents: on two consecutive days the pupil of one of the eyes of 28 subjects was dilated with tropicamide 1%, and the pupil of one of the eyes of 30 subjects was dilated with cyclopentolate hydrochloride 1%. The other eyes in both groups were dilated only on the second day, and thus served as controls. Pupil sizes were measured from photographs before and after dilation. The pupils of the eyes treated twice with either drug did not dilate as well after the second dose as those of the control eyes (P less than .005 for tropicamide, P less than .001 for cyclopentolate). The pupils of the eyes twice-treated with tropicamide were an average of 0.15 mm smaller than the control pupils; those twice-treated with cyclopentolate were 0.36 mm smaller. For subjects treated with cyclopentolate, this decreased mydriasis was related to age (P less than .05) and to eye color (P less than .025): the younger and blue-eyed subjects dilated less on the second day than the older and brown-eyed subjects. If full mydriasis is required at surgery, pupils should probably not be dilated with either tropicamide or cyclopentolate the day before surgery.
术前一天及手术当天,通常会散瞳进行检查。进行了以下实验以确定两种常用散瞳剂的连续剂量的效果:连续两天,28名受试者一只眼睛的瞳孔用1%托吡卡胺散瞳,30名受试者一只眼睛的瞳孔用1%盐酸环喷托酯散瞳。两组的另一只眼睛仅在第二天散瞳,因此作为对照。通过散瞳前后的照片测量瞳孔大小。用任何一种药物进行两次治疗的眼睛的瞳孔在第二次给药后扩张程度不如对照眼睛(托吡卡胺P<0.005,环喷托酯P<0.001)。用托吡卡胺进行两次治疗的眼睛的瞳孔平均比对照瞳孔小0.15毫米;用环喷托酯进行两次治疗的眼睛的瞳孔小0.36毫米。对于用环喷托酯治疗的受试者,这种散瞳减弱与年龄(P<0.05)和眼睛颜色(P<0.025)有关:年轻和蓝眼睛的受试者在第二天的散瞳程度低于年长和棕色眼睛的受试者。如果手术时需要充分散瞳,术前一天可能不应使用托吡卡胺或环喷托酯散瞳。